Save icon

Save on Tresiba®

Chatbot icon


I can help

Please tell me what you're looking for

Why Tresiba®

Tresiba® is a long-acting insulin for people 1 year of age and older with type 1 and type 2 diabetes that manages blood sugar for 24 hours, for powerful A1C reduction.

actor portrayal

Reasons to Ask About Tresiba®

Clock icon

Manages blood sugar for 24 hours

A1C icon

Powerful A1C reduction

Health insurance coverage icon

Covered by most major health insurance plans

Once-daily dosing icon

Once-daily dosing

Only Tresiba® allows adults to vary their daily dosing interval by 8 to 40 hours, providing around­-the-clock control while still maintaining blood sugar control. Taking your insulin at the same time every day is recommended, but if you miss or delay your Tresiba® dose, simply take it as soon as you can, then return to your normal dosing schedule. Just be sure to leave at least 8 hours between doses.

Tresiba® in Action

A slow and steady release that works the way the body’s insulin does

For adults, if you miss or delay your Tresiba® dose, simply take it as soon as you can, then return to your normal dosing schedule. Just be sure to leave at least 8 hours between doses.

FlexTouch®: Another Reason to Ask About Tresiba®

The latest in prefilled insulin pen technology from Novo Nordisk

  • Tresiba® FlexTouch® pen lasts up to 8 weeks once in use if it is refrigerated or kept at room temperature up to 86°Fa
  • Accurate dosing to 160 units with Tresiba® U-200
  • No push-button extension: Tresiba® FlexTouch® has a spring-loaded mechanism that allows the push button to stay in place at any dose. Other prefilled injection pens have a push button that extends when the dose is dialed up
  • Also available in a vial 

aOpened (in-use) Tresiba® FlexTouch® should be refrigerated (36°F to 46°F [2°C to 8°C]) or kept at room temperature (up to 86°F [30°C]), away from direct heat and light.

Tresiba® Was Studied for Safety 

In a large safety study vs Lantus® in adults with type 2 diabetes and heart disease, Tresiba® did not increase their risk of major cardiovascular events, such as heart attack, stroke, or death. 

Compared to Lantus®, Tresiba® also had a lower rate of severe low blood sugar, a possible serious side effect of insulin.

The goal of any diabetes treatment is to lower blood sugar. However, it is possible for your blood sugar to drop too low. Ask your health care provider what blood sugar level is considered low for you. 

Learn more about hypoglycemia from the downloadable fact sheet.


Save on Tresiba®

You may pay as little as $35 or no more than $99 per prescription.b

Start saving
NEXT: How Tresiba® works
html source